Albuminuria and the risk of incident stroke and stroke types in older adults
暂无分享,去创建一个
M. Shlipak | M. Sarnak | R. Katz | S. Seliger | W. Longstreth | M. Aguilar | R. Hart | P. Pergola | D. Rifkin | E. O'Meara | R. Katz | Michael G Shlipak | W. Longstreth | Maria I. Aguilar | E. S. O'Meara | Robert G. Hart | M. Shlipak | W. T. Longstreth
[1] K. Nakashima,et al. [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[2] L. Price,et al. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] C. Jack,et al. Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships , 2008, Journal of the Neurological Sciences.
[4] J. Danziger. Importance of low-grade albuminuria. , 2008, Mayo Clinic proceedings.
[5] B. Astor,et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. , 2008, American journal of epidemiology.
[6] C. Schmid,et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] C. DeCarli,et al. Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) , 2007, Stroke.
[8] R. Hui,et al. Cystatin C, Associated With Hemorrhagic and Ischemic Stroke, Is a Strong Predictor of the Risk of Cardiovascular Events and Death in Chinese , 2007, Stroke.
[9] A. Hofman,et al. Decreased Glomerular Filtration Rate Is a Risk Factor for Hemorrhagic But Not for Ischemic Stroke: The Rotterdam Study , 2007, Stroke.
[10] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[11] Takeo Kato,et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects , 2007, Journal of the Neurological Sciences.
[12] B. Kestenbaum,et al. Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease , 2006, Annals of Internal Medicine.
[13] L. Kuller,et al. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. , 2006, Atherosclerosis.
[14] Anne Newman,et al. Cystatin C and subclinical brain infarction. , 2005, Journal of the American Society of Nephrology : JASN.
[15] D. Levy,et al. Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.
[16] D. Siscovick,et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.
[17] B. Psaty,et al. Cystatin-C and mortality in elderly persons with heart failure. , 2005, Journal of the American College of Cardiology.
[18] D. E. Busby,et al. Comparison of Commonly Used Assays for the Detection of Microalbuminuria , 2004, Journal of clinical hypertension.
[19] R. Klein,et al. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] M. Nieminen,et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. , 2004, Annals of internal medicine.
[21] M. Nieminen,et al. Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study , 2003, Annals of Internal Medicine.
[22] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.
[23] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[24] S. Romundstad,et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] G. Eknoyan,et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.
[26] J. Coresh,et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.
[27] A. Słowik,et al. Microalbuminuria in Nondiabetic Patients with Acute Ischemic Stroke: Prevalence, Clinical Correlates, and Prognostic Significance , 2002, Cerebrovascular Diseases.
[28] S. Yusuf,et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.
[29] C. Furberg,et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study , 2001, Neurology.
[30] David Roth,et al. A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .
[31] M. Schroll,et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.
[32] M. Rodríguez-Moran,et al. Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus. , 1999, Stroke.
[33] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[34] H. Gerstein,et al. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. , 1997, Archives of internal medicine.
[35] M. Fantone,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.
[36] B M Psaty,et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1991, Stroke.
[37] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[38] P M Rautaharju,et al. Methodology of ECG Interpretation in the Dalhousie Program; NOVACODE ECG Classification Procedures for Clinical Trials and Population Health Surveys , 1990, Methods of Information in Medicine.
[39] Jasmin A. Tiro,et al. Non-Insulin-Dependent Diabetes Mellitus , 2006 .